BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families

por Claes, K, Poppe, B, Coene, I, Paepe, A De, Messiaen, L
Publicado 2004

Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition

por Baeyens, A, Thierens, H, Claes, K, Poppe, B, Messiaen, L, De Ridder, L, Vral, A
Publicado 2002

Genetic Counselling and Testing for Hereditary Breast and Ovarian Cancer: The Gent(le) Approach

por De Vos, M., Poppe, B., Delvaux, I., Mortier, G., Claes, K., Messiaen, L., De Paepe, A.
Publicado 1999

On-line beam monitoring and dose profile measurements of a $^{208}$Pb beam of 150 GeV/n with a liquid-filled ionization chamber array

por Wyrwoll, V, Delfs, B, Lapp, M, Poppinga, D, Fernandéz Martinéz, P, Kastriotou, M, García Alía, R, Røed, K, Gerbershagen, A, Looe, H K, Poppe, B
Publicado 2021

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

por Osher, D J, De Leeneer, K, Michils, G, Hamel, N, Tomiak, E, Poppe, B, Leunen, K, Legius, E, Shuen, A, Smith, E, Arseneau, J, Tonin, P, Matthijs, G, Claes, K, Tischkowitz, M D, Foulkes, W D
Publicado 2012

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

por Francies, F. Z., Wainstein, T., De Leeneer, K., Cairns, A., Murdoch, M., Nietz, S., Cubasch, H., Poppe, B., Van Maerken, T., Crombez, B., Coene, I., Kerr, R., Slabbert, J. P., Vral, A., Krause, A., Baeyens, A., Claes, K. B. M.
Publicado 2015